SCHEMBL4969367

SCHEMBL4969367

O=C(O)N1CCC(N2CCN(c3ccccc3)CC2)CC1

nearest known ligand 0.67

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 9/20 0.67
CYP2C9 P11712 1/20 0.67
CYP2C19 P33261 1/20 0.67
ALDH1A1 P00352 7/20 0.65
L3MBTL1 Q9Y468 4/20 0.65
MAPT P10636 4/20 0.65
THRB P10828 1/20 0.65
HIF1A Q16665 2/20 0.64
MEN1 O00255 1/20 0.64
KMT2A Q03164 1/20 0.64
L3MBTL3 Q96JM7 2/20 0.60
MBTD1 Q05BQ5 1/20 0.60
TDP1 Q9NUW8 1/20 0.60
GRIN2B Q13224 1/20 0.59
GAA P10253 1/20 0.58
CXCR4 P61073 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL631962 0.82 ALDH1A1 (0.69) CYP2C9CYP2C19ALDH1A1MAPTMEN1
SCHEMBL14161697 0.82 GRIN2B (0.76) KDM4ECYP2C9CYP2C19ALDH1A1L3MBTL1
Hydrochloric Acid SCHEMBL5492248 0.81 ALDH1A1 (0.67) CYP2C9CYP2C19ALDH1A1MAPTMEN1
SCHEMBL2959519 0.81 GPR119 (0.74) KDM4ECYP2C9CYP2C19ALDH1A1L3MBTL1
SCHEMBL3570969 0.80 GFER (0.53) KDM4ECYP2C9CYP2C19ALDH1A1L3MBTL1
SCHEMBL13648726 0.79 L3MBTL3 (0.72) KDM4EALDH1A1L3MBTL1MAPTHIF1A
SCHEMBL13648728 0.79 L3MBTL3 (0.72) KDM4ECYP2C9CYP2C19ALDH1A1L3MBTL1
SCHEMBL16151520 0.79 KDM4E (0.67) KDM4ECYP2C9CYP2C19ALDH1A1L3MBTL1
SCHEMBL2550326 0.78 L3MBTL3 (0.46) KDM4EALDH1A1L3MBTL1L3MBTL3MBTD1
SCHEMBL13200798 0.78 GRIN2B (0.70) KDM4ECYP2C9CYP2C19ALDH1A1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1960359-A1 NOVEL N-SULFAMOYL-PIPERIDINEAMIDES FOR THE PROPHYLAXIS OR TREATMENT OF OBESITY AND RELATED CONDITIONS Solvay Pharmaceuticals GmbH (DE) 2008-08-27 EP disclosed
WO-2007065948-A1 NOVEL N-SULFAMOYL-PIPERIDINEAMIDES FOR THE PROPHYLAXIS OR TREATMENT OF OBESITY AND RELATED CONDITIONS SOLVAY PHARMACEUTICALS GMBH (DE) 2007-06-14 WO disclosed